ClinConnect ClinConnect Logo
Search / Trial NCT05706220

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Launched by INSTITUTO UNIVERSITARIO DE OFTALMOBIOLOGÍA APLICADA (INSTITUTE OF APPLIED OPHTHALMOBIOLOGY) - IOBA · Jan 20, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Ocular Motility Disorders Eye Movement Eye Tracking Microperimetry Fixational Eye Movements Visual Processing Speed Optical Coherence Tomography

ClinConnect Summary

Anamnesis, ophthalmological medical history including difficulties in reading with appropriate glasses.

The following protocol will be applied:

* Comprehensive eye examination
* Stereopsis
* Primary gaze position
* Cover test: far and near
* Vergence and version eye movements
* Presence of nystagmus
* Far and near best corrected visual acuity, with updated refraction

-.Pupillary light reflex
* Biomicroscopy of the anterior pole
* Intraocular pressure
* Recording of eye movements during two standardized tests: International Reading Speed Texts test (IReST®) and Developmental Eye Movemen...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of Multiple Sclerosis
  • Best distant corrected visual acuity equal or greater than 0.7 (decimal scale). Glasses or soft contact lenses users.
  • Best close corrected visual acuity equal to or greater than 20/30 (Snellen scale).Glasses or soft contact lenses users.
  • Exclusion Criteria:
  • Patients with a history of acute optic neuritis (ON) and/or who experienced an episode of ON \<6 months prior to the study, to avoid potential interference of papilledema with accurate peripapillary RNFL thickness measurements.
  • Patients with other retinal and optic nerve diseases, advanced cataracts according to the international Lens Opacities Classification System III (LOCS III) (opacities greater than C2N2)
  • Patients with other ophthalmological diseases that could affect central visual acuity
  • Subjects with high refractive error (+ - 6 diopters).
  • Subjects with other demyelinating disorders (neuromyelitis optica or acute disseminated encephalomyelitis).

About Instituto Universitario De Oftalmobiología Aplicada (Institute Of Applied Ophthalmobiology) Ioba

The Instituto Universitario de Oftalmobiología Aplicada (IOBA) is a leading research institution dedicated to advancing the field of ophthalmology through innovative clinical trials and applied research. Based at the intersection of academia and healthcare, IOBA focuses on developing cutting-edge therapies and diagnostic tools for ocular diseases, aiming to enhance patient outcomes and contribute to the global body of knowledge in vision science. With a team of expert researchers and clinicians, IOBA fosters collaboration and knowledge transfer, striving to translate scientific advancements into practical solutions for eye health.

Locations

Valladolid, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials